ESR1 and neoplasm: Furthermore, positive HER2 status, lack of estrogen receptor expression (ER-), ductal tumor histology, small tumor size (T1/2), and M0 metastatic status were identified as risk factors for the development of cerebral metastasis by Heitz et al.